Neurosurgical grade biomaterial, DuraGenTM, offers a promising matrix for protected delivery of neural stem cells in clinical cell therapies
Louise Finch, Christopher Adams, Jon Sen, Jacqueline Tickle, Nikolaos Tzerakis and Divya Maitreyi Chari
DOI: https://doi.org/10.7861/futurehosp.6-1-s76
Future Healthc J March 2019 Louise Finch
AInstitute for Science and Technology in Medicine, Keele University, Stoke-on-Trent, UK
Christopher Adams
BFaculty of Natural Sciences, Keele University, Stoke-on-Trent, UK
Jon Sen
AInstitute for Science and Technology in Medicine, Keele University, Stoke-on-Trent, UK
CNeurosurgery department, HCA Healthcare, London, UK
Jacqueline Tickle
AInstitute for Science and Technology in Medicine, Keele University, Stoke-on-Trent, UK
Nikolaos Tzerakis
DNeurosurgery department, University Hospitals of North Midlands, Stoke-on-Trent, UK
Divya Maitreyi Chari
AInstitute for Science and Technology in Medicine, Keele University, Stoke-on-Trent, UK
Article Tools
Neurosurgical grade biomaterial, DuraGenTM, offers a promising matrix for protected delivery of neural stem cells in clinical cell therapies
Louise Finch, Christopher Adams, Jon Sen, Jacqueline Tickle, Nikolaos Tzerakis, Divya Maitreyi Chari
Future Healthc J Mar 2019, 6 (Suppl 1) 76; DOI: 10.7861/futurehosp.6-1-s76
Citation Manager Formats
Neurosurgical grade biomaterial, DuraGenTM, offers a promising matrix for protected delivery of neural stem cells in clinical cell therapies
Louise Finch, Christopher Adams, Jon Sen, Jacqueline Tickle, Nikolaos Tzerakis, Divya Maitreyi Chari
Future Healthc J Mar 2019, 6 (Suppl 1) 76; DOI: 10.7861/futurehosp.6-1-s76
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.